ABSTRACT
A new series of butene lactone derivatives were designed according to an influenza neuraminidase target and their antiviral activities against H1N1 infection of Madin-Darby canine kidney cells were evaluated. Among them, a compound that was given the name M355 was identified as the most potent against H1N1 (EC50 = 14.7 µM) with low toxicity (CC50 = 538.13 µM). It also visibly reduced the virus-induced cytopathic effect. Time-of-addition analysis indicated that H1N1 was mostly suppressed by M355 at the late stage of its infectious cycle. M355 inhibited neuraminidase in a dose-dependent fashion to a similar extent as oseltamivir, which was also indicated by a computer modeling experiment. In a mouse model, lung lesions and virus load were reduced and the expression of nucleoprotein was moderated by M355. The enzyme-linked immunosorbent assay and quantitative real-time polymerase chain reaction analyses revealed that the levels of interferon-γ, interferon regulatory factor-3, Toll-like receptor-3, tumor necrosis factor-α, interleukin (IL)-1ß, IL-6, and IL-8 were downregulated in the M355-treated groups, whereas the levels of IL-10 and IL-13 were upregulated. Similarly, IgG was found to be increased in infected mice plasma. These results demonstrate that M355 inhibit the expression of H1N1 in both cellular and animal models. Thus, M355 has the potential to be effective in the treatment of influenza A virus infection.
Subject(s)
Alkenes , Antiviral Agents , Influenza A Virus, H1N1 Subtype , Lactones , Orthomyxoviridae Infections , Alkenes/pharmacology , Animals , Antiviral Agents/pharmacology , Dogs , Influenza A Virus, H1N1 Subtype/drug effects , Lactones/pharmacology , Madin Darby Canine Kidney Cells , Mice , Neuraminidase , Orthomyxoviridae Infections/drug therapyABSTRACT
The development of a SYBR Green-based duplex real-time PCR is described for simultaneous detection of porcine parvovirus (PPV) and porcine circovirus type 2 (PCV-2) genomes. Viral genomes were identified in the same sample by their distinctive melting temperature (T(m)) which is 77.5°C for PPV VP2 313bp amplicon and 82.3°C for PCV-2 ORF2 171bp amplicon, respectively. The detection limit of the method was 0.01TCID(50)/mL for PPV and PCV-2, about 10 times more sensitive than conventional PCR. In addition, PPV and PCV-2 viral load were measured in 126 field samples, confirming the sensitivity and specificity, and the result showed that 70/126 samples were positive for PPV and 92/126 samples were positive for PCV2 by the duplex real-time PCR. This method may be a useful alternative rapid and reliable method for the detection of PPV/PCV-2 co-infection.
Subject(s)
Circoviridae Infections , Circovirus/genetics , Parvoviridae Infections , Parvovirus, Porcine/genetics , Animals , Benzothiazoles , Circoviridae Infections/diagnosis , Circoviridae Infections/veterinary , Circoviridae Infections/virology , Coinfection , DNA Primers , DNA, Viral/analysis , Diamines , Limit of Detection , Nucleic Acid Denaturation , Organic Chemicals , Parvoviridae Infections/diagnosis , Parvoviridae Infections/veterinary , Parvoviridae Infections/virology , Quinolines , Real-Time Polymerase Chain Reaction , Sensitivity and Specificity , Swine , Swine Diseases/diagnosis , Swine Diseases/virology , Viral LoadABSTRACT
Inactivated porcine parvovirus (PPV) vaccines are available commercially and widely used in the breeding herds. However, inactivated PPV vaccines have deficiencies in induction of specific cellular immune response. Transfer factor (TF) is a material that obtained from the leukocytes, and is a novel immune-stimulatory reagent that as a modulator of the immune system. In this study, the immunogenicity of PPV oil emulsion vaccine and the immuno-regulatory activities of TF were investigated. The inactivated PPV oil emulsion vaccines with or without TF were inoculated into BALB/c mice by subcutaneous injection. Then humoral and cellular immune responses were evaluated by indirect enzyme-linked immunosorbent assays (ELISA), fluorescence-activated cell sorter analyses (FACS). The results showed that the PPV specific immune responses could be evoked in mice by inoculating with PPV oil emulsion vaccine alone or by co-inoculation with TF. The cellular immune response levels in the co-inoculation groups were higher than those groups receiving the PPV oil emulsion vaccine alone, with the phenomena of higher level of IFN-γ, a little IL-6 and a trace of IL-4 in serum, and a vigorous T-cell response. However, there was no significant difference in antibody titers between TF synergy inactivated vaccine and the inactivated vaccine group (P>0.05). In conclusion, these results suggest that TF possess better cellular immune-enhancing capability and would be exploited into an effective immune-adjuvant for inactivated vaccines.
Subject(s)
Parvovirus, Porcine/immunology , Transfer Factor/administration & dosage , Viral Vaccines/immunology , Adjuvants, Immunologic/administration & dosage , Animals , Antibodies, Viral/blood , Antibodies, Viral/immunology , Emulsions/administration & dosage , Enzyme-Linked Immunosorbent Assay , Female , Immunity, Cellular , Immunity, Humoral , Interferon-gamma/blood , Interferon-gamma/metabolism , Interleukin-4/blood , Interleukin-4/metabolism , Interleukin-6/blood , Interleukin-6/metabolism , Leukocytes, Mononuclear/immunology , Lymphocytes/immunology , Male , Mice , Mice, Inbred BALB C , Models, Animal , Swine , Vaccination/veterinary , Vaccines, Inactivated/immunologyABSTRACT
The immunogenicity of an infectious laryngotracheitis virus (ILTV) glycoprotein B (gB) plasmid DNA vaccine and the immunoregulatory activity of chicken interleukin-18 (IL-18) were investigated in a challenge model. Two recombinant plasmids, pcDNA3.1/gB (pgB) and pcDNA3.1/IL-18 (pIL-18), containing gB and IL-18 were constructed. Chickens were intramuscularly administered two immunizations 2 weeks apart, and challenged with the virulent CG strain of ILTV 2 weeks later. All animals vaccinated with pgB alone or with a combination of pgB plus pIL-18 developed a specific anti-ILTV ELISA antibody and splenocyte proliferation response. The ratios of CD4(+) to CD8(+) T lymphocytes in chickens immunized with pgB plus pIL-18 were significantly higher than in those immunized with pgB alone. Co-injection of pIL-18 significantly increased the production of gamma interferon and IL-2, indicating that IL-18 enhances the T helper 1-dominant immune response. Challenge experiments showed that the morbidity rate in the pgB group (25 â%) was significantly higher than that in the pgB plus pIL-18 group (10â %). The mortality rates in the pgB and pgB plus pIL-18 groups were 10 and 0â%, respectively, and the corresponding protection rates were 60 and 80â %. These results indicate that IL-18 may be an effective adjuvant for an ILTV vaccine.
Subject(s)
Herpesviridae Infections/veterinary , Interleukin-18/immunology , Poultry Diseases/prevention & control , Vaccines, DNA/immunology , Viral Envelope Proteins/immunology , Viral Vaccines/immunology , Animals , Antibodies, Viral/blood , CD4-CD8 Ratio , Cell Proliferation , Chickens , Cytokines/metabolism , DNA, Viral/genetics , DNA, Viral/isolation & purification , Enzyme-Linked Immunosorbent Assay/methods , Herpesviridae Infections/mortality , Herpesviridae Infections/pathology , Herpesviridae Infections/prevention & control , Herpesvirus 1, Gallid/genetics , Herpesvirus 1, Gallid/immunology , Immunization, Secondary/methods , Injections, Intramuscular , Interleukin-18/genetics , Plasmids/administration & dosage , Polymerase Chain Reaction/methods , Poultry Diseases/mortality , Poultry Diseases/pathology , Survival Analysis , T-Lymphocyte Subsets/immunology , Trachea/virology , Vaccination/methods , Vaccines, DNA/administration & dosage , Vaccines, DNA/genetics , Viral Envelope Proteins/genetics , Viral Vaccines/administration & dosage , Viral Vaccines/geneticsABSTRACT
Infectious bronchitis virus (IBV) poses a major threat to the chicken industry worldwide. In this study, we developed a recombinant fowlpox virus (rFPV) vaccine expressing the IBV S1 gene and chicken interleukin-18 gene (IL-18), rFPV-S1/IL18. Recombinant plasmid pSY-S1/IL18 was constructed by cloning chicken IL-18 into fowlpox virus transfer plasmid containing S1 gene and transfected into the chicken embryo fibroblasts cell pre-infected with S-FPV-017 to generate rFPV-S1/IL18. Expression of the recombinant proteins was confirmed by RT-PCR and IFA. We also constructed the recombinant fowlpox virus rFPV-S1 without IL-18. One-day-old chickens were vaccinated by wing-web puncture with the two rFPVs, and the induced humoral and cellular responses were evaluated. There was a significant difference in ELISA antibody levels (P<0.05) elicited by either rFPV-S1 or rFPV-S1/IL18. The ratios of CD4(+) to CD8(+) in chickens immunized with rFPV-S1/IL18 were significantly higher (P<0.05) than in those immunized with rFPV-S1. All chickens immunized with rFPV-S1/IL18 were completely protected (20/20) after challenge with the virulent IBV HN99 strain 43 days after immunization, while only 15 out of 20 of the chickens immunized with the rFPV-S1 were protected. Our results show that the protective efficacy of the rFPV-S1 vaccine could be enhanced significantly by simultaneous expression of IL-18.